EP1545470A2 - Compositions antimicrobiennes et procedes d'utilisation correspondants - Google Patents

Compositions antimicrobiennes et procedes d'utilisation correspondants

Info

Publication number
EP1545470A2
EP1545470A2 EP03766897A EP03766897A EP1545470A2 EP 1545470 A2 EP1545470 A2 EP 1545470A2 EP 03766897 A EP03766897 A EP 03766897A EP 03766897 A EP03766897 A EP 03766897A EP 1545470 A2 EP1545470 A2 EP 1545470A2
Authority
EP
European Patent Office
Prior art keywords
turmeric
extract
composition
green tea
ginger
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03766897A
Other languages
German (de)
English (en)
Other versions
EP1545470A4 (fr
Inventor
Richard A. Rosenbloom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quigley Corp
Original Assignee
Quigley Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/024794 external-priority patent/WO2003013428A2/fr
Priority claimed from US10/359,889 external-priority patent/US7396546B2/en
Application filed by Quigley Corp filed Critical Quigley Corp
Publication of EP1545470A2 publication Critical patent/EP1545470A2/fr
Publication of EP1545470A4 publication Critical patent/EP1545470A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne une composition antimicrobienne. Cette composition comprend un premier ingrédient obtenu à partir du gingembre, un deuxième ingrédient obtenu à partir du thé vert, un troisième ingrédient facultatif provenant du curcuma, et, éventuellement, un véhicule acceptable. L'invention concerne également des procédés destinés à réduire, traiter ou prévenir au moins un symptôme ou un effet indésirable d'infection microbienne chez un patient. Le procédé comprend l'étape consistant à administrer au patient avant, pendant ou après une exposition à un microbe, une quantité efficace d'une composition de l'invention.
EP03766897A 2002-08-06 2003-07-24 Compositions antimicrobiennes et procedes d'utilisation correspondants Withdrawn EP1545470A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PCT/US2002/024794 WO2003013428A2 (fr) 2001-08-06 2002-08-06 Complements nutritionnels et leurs procedes d'utilisation
WOPCT/US02/24794 2002-08-06
US359889 2003-02-06
US10/359,889 US7396546B2 (en) 2001-08-06 2003-02-06 Anti-microbial compositions and methods of using same
PCT/US2003/023125 WO2004012655A2 (fr) 2002-08-06 2003-07-24 Compositions antimicrobiennes et procedes d'utilisation correspondants

Publications (2)

Publication Number Publication Date
EP1545470A2 true EP1545470A2 (fr) 2005-06-29
EP1545470A4 EP1545470A4 (fr) 2009-07-01

Family

ID=34549101

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03766897A Withdrawn EP1545470A4 (fr) 2002-08-06 2003-07-24 Compositions antimicrobiennes et procedes d'utilisation correspondants

Country Status (10)

Country Link
EP (1) EP1545470A4 (fr)
JP (1) JP2005534699A (fr)
CN (1) CN1674875A (fr)
AU (1) AU2003256736B2 (fr)
CA (1) CA2495447A1 (fr)
HK (1) HK1082660A1 (fr)
IL (1) IL166608A0 (fr)
MX (1) MXPA05001051A (fr)
NZ (1) NZ537821A (fr)
WO (1) WO2004012655A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166435B2 (en) * 2001-08-06 2007-01-23 The Quigley Corporation Compositions and methods for reducing the transmissivity of illnesses
NZ526098A (en) * 2003-05-23 2005-10-28 Enzo Nutraceuticals Ltd Use of a plant extract containing flavonoids rich in proanthocyanidins for the prevention or treatment of migraine
CA2567766C (fr) * 2004-07-07 2012-10-02 Mitsui Norin Co., Ltd Biocides et desinfectants durables
JP4788994B2 (ja) * 2005-01-26 2011-10-05 独立行政法人農業・食品産業技術総合研究機構 機能性飲食品
JP5032003B2 (ja) * 2005-06-15 2012-09-26 株式会社琉球バイオリソース開発 口腔粘膜用の鎮痛・抗炎症トローチ剤
FR2887748B1 (fr) * 2005-06-29 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires.
FR2887749B1 (fr) * 2005-06-29 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires
WO2007039262A1 (fr) * 2005-09-30 2007-04-12 Dsm Ip Assets B.V. Nouvelles préparations contenant des polyphénols
CA2883256A1 (fr) * 2006-03-10 2007-09-20 N.V. Nutricia Utilisation de saccharides non digestibles pour renforcer le systeme immunitaire
JP5207341B2 (ja) * 2006-10-26 2013-06-12 独立行政法人産業技術総合研究所 炎症性サイトカイン産生抑制剤
WO2008074031A1 (fr) * 2006-12-14 2008-06-19 The Quigley Corporation Compositions et procédés pour traiter la bronchite infectieuse
JP2010513312A (ja) * 2006-12-14 2010-04-30 ザ キグリー コーポレーション ニューカッスル病の発症を治療および軽減する方法
KR101077920B1 (ko) 2009-07-08 2011-10-31 한국생명공학연구원 울금 추출물을 포함하는 인플루엔자 바이러스 감염의 예방 및 치료용 조성물 및 뉴라미니데이즈 활성의 억제용 조성물
KR101121615B1 (ko) 2009-09-14 2012-02-28 주식회사 바이오에프디엔씨 항균용 세정제 조성물
KR100962334B1 (ko) * 2009-10-19 2010-06-10 주식회사 중앙백신연구소 울금으로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제
EP2490703B1 (fr) 2009-10-22 2015-09-09 Maresins Pharma, Inc. Composition à base d'herbe médicinale comprenant du gingembre et de la verge d'or pour le traitement d'une infection d'influenza
ITMI20111259A1 (it) * 2011-07-06 2013-01-07 Eye Tech Srl Composizione orosolubile a rapida disgregazione contenente derivati di curcumina
JP2013100253A (ja) * 2011-11-09 2013-05-23 Shigeru Abe ショウガ成分を含む抗カンジダ活性組成物
US20140294990A1 (en) * 2013-03-27 2014-10-02 Timothy P. O'Connor Throat gargle tablet and method of use thereof
EP3103465A1 (fr) * 2015-06-10 2016-12-14 Raman Mehta Formulations pour le traitement de lésions de muqueuses
JP2019011279A (ja) * 2017-06-30 2019-01-24 小林製薬株式会社 下痢抑制剤
CN117338758B (zh) * 2023-12-06 2024-03-12 北京远大九和药业有限公司 一种药物组合物及其用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6032705A (ja) * 1983-08-02 1985-02-19 Shiraimatsu Shinyaku Kk 抗微生物剤
JPH02276562A (ja) * 1989-04-19 1990-11-13 Mitsui Norin Kk 抗菌剤
JPH07111857A (ja) * 1993-10-21 1995-05-02 Bioole Chem:Kk 茶の葉
JPH11302121A (ja) * 1998-04-16 1999-11-02 Fuudeiamu Tokunaga:Kk 緑茶カテキンを用いた抗菌剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0319670A (ja) * 1989-06-17 1991-01-28 Chieko Shiroi ウコン混合の穀物及びその加工食品
CN1060012A (zh) * 1991-09-20 1992-04-08 沈阳市铁西区科发医药饮料技术服务部 一种口香糖的制作方法
CN1072823A (zh) * 1992-06-13 1993-06-09 文士开 果酶茶的配制方法
CN1116068A (zh) * 1994-01-25 1996-02-07 刘俊松 天然乳化果茶主剂的制备方法
JPH10130161A (ja) * 1996-09-06 1998-05-19 Otsuka Pharmaceut Co Ltd ヘリコバクター・ピロリに対する組成物
JPH10279432A (ja) * 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The 組成物
JP2000212094A (ja) * 1998-11-18 2000-08-02 Takeda Chem Ind Ltd 口腔用製剤
JP2000157209A (ja) * 1998-11-27 2000-06-13 Kagetoshi Kawauchi 振り掛け健康食品
US6264995B1 (en) * 1999-10-19 2001-07-24 Thomas Newmark Herbal composition for reducing inflammation and methods of using same
US6261607B1 (en) * 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
US6596313B2 (en) * 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6032705A (ja) * 1983-08-02 1985-02-19 Shiraimatsu Shinyaku Kk 抗微生物剤
JPH02276562A (ja) * 1989-04-19 1990-11-13 Mitsui Norin Kk 抗菌剤
JPH07111857A (ja) * 1993-10-21 1995-05-02 Bioole Chem:Kk 茶の葉
JPH11302121A (ja) * 1998-04-16 1999-11-02 Fuudeiamu Tokunaga:Kk 緑茶カテキンを用いた抗菌剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2004012655A2 *

Also Published As

Publication number Publication date
IL166608A0 (en) 2006-01-15
NZ537821A (en) 2007-05-31
AU2003256736A1 (en) 2004-02-23
MXPA05001051A (es) 2005-04-08
WO2004012655A3 (fr) 2004-09-16
JP2005534699A (ja) 2005-11-17
CA2495447A1 (fr) 2004-02-12
EP1545470A4 (fr) 2009-07-01
CN1674875A (zh) 2005-09-28
HK1082660A1 (zh) 2006-06-16
WO2004012655A2 (fr) 2004-02-12
AU2003256736B2 (en) 2009-09-10

Similar Documents

Publication Publication Date Title
US7396546B2 (en) Anti-microbial compositions and methods of using same
US6827945B2 (en) Nutritional supplements and methods of using same
AU2002332464B2 (en) Nutritional supplements and methods of using same
AU2003256736B2 (en) Anti-microbial compositions and methods of using same
AU2002332464A1 (en) Nutritional supplements and methods of using same
US7175987B2 (en) Compositions and methods for treatment of herpes
US7507425B2 (en) Method for the treatment of cachexia
US7405046B2 (en) Compositions and methods for treatment of rhinovirus
KR20050033069A (ko) 항생 조성물 및 그 사용 방법
ZA200500517B (en) Anti-microbial compositions and methods of using same.
Sao et al. Assesment of Antidiabetic and Liver Protective effect of “sankat mochan drops”: A Polyherbal Marketed Formulation
RATHOUR et al. Review on Syzygium cumini Linn: A promising ethnopharmacological plant.
Ross 16 Zingiber

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050224

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1082660

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20090529

17Q First examination report despatched

Effective date: 20091116

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100329

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1082660

Country of ref document: HK